Patents by Inventor Sandip P. Mehta

Sandip P. Mehta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liquid oral formulations for tadalafil
    Patent number: 11975006
    Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
    Type: Grant
    Filed: April 28, 2023
    Date of Patent: May 7, 2024
    Assignee: LIQMEDS WORLDWIDE LIMITED
    Inventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
  • Aqueous suspension suitable for oral administration
    Patent number: 11925704
    Abstract: The present invention provides liquid oral dosage form of lipid lowering agent suitable for oral administration to human or animals.
    Type: Grant
    Filed: April 14, 2023
    Date of Patent: March 12, 2024
    Assignee: LIQMEDS WORLDWIDE LIMITED
    Inventors: Sandip P. Mehta, Henil Alpeshbhai Patel, Jayanta Kumar Mandal
  • LIQUID ORAL FORMULATIONS FOR SILDENAFIL
    Publication number: 20230381187
    Abstract: The present disclosure is directed to pharmaceutical compositions comprising sildenafil or a pharmaceutically acceptable salt thereof and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of sildenafil or a pharmaceutically acceptable salt thereof such as pulmonary arterial hypertension, erectile dysfunction, etc.
    Type: Application
    Filed: August 4, 2023
    Publication date: November 30, 2023
    Applicant: LIQMEDS WORLDWIDE LIMITED
    Inventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
  • Liquid oral formulations for sildenafil
    Patent number: 11759468
    Abstract: The present disclosure is directed to pharmaceutical compositions comprising sildenafil or a pharmaceutically acceptable salt thereof and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of sildenafil or a pharmaceutically acceptable salt thereof such as pulmonary arterial hypertension, erectile dysfunction, etc.
    Type: Grant
    Filed: August 31, 2022
    Date of Patent: September 19, 2023
    Assignee: LIQMEDS WORLDWIDE LIMITED
    Inventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
  • LIQUID ORAL FORMULATIONS FOR TADALAFIL
    Publication number: 20230285398
    Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
    Type: Application
    Filed: April 28, 2023
    Publication date: September 14, 2023
    Applicant: LiqMeds Worldwide Limited
    Inventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
  • AQUEOUS SUSPENSION SUITABLE FOR ORAL ADMINISTRATION
    Publication number: 20230248645
    Abstract: The present invention provides liquid oral dosage form of lipid lowering agent suitable for oral administration to human or animals.
    Type: Application
    Filed: April 14, 2023
    Publication date: August 10, 2023
    Applicant: LIQMEDS WORLDWIDE LIMITED
    Inventors: Sandip P. MEHTA, Henil Alpeshbhai PATEL, Jayanta Kumar MANDAL
  • ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PROCESS OF PREPARATION THEREOF
    Publication number: 20230241036
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Application
    Filed: February 27, 2023
    Publication date: August 3, 2023
    Inventors: Swati NAGAR, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Sandeep PAL
  • ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PROCESS OF PREPARATION THEREOF
    Publication number: 20230218586
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Application
    Filed: February 27, 2023
    Publication date: July 13, 2023
    Inventors: Swati NAGAR, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Sandeep PAL
  • Liquid oral formulations for tadalafil
    Patent number: 11666576
    Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
    Type: Grant
    Filed: June 6, 2022
    Date of Patent: June 6, 2023
    Assignee: LIQMEDS WORLDWIDE LIMITED
    Inventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
  • Aqueous suspension suitable for oral administration
    Patent number: 11654106
    Abstract: The present invention provides liquid oral dosage form of lipid lowering agent suitable for oral administration to human or animals.
    Type: Grant
    Filed: May 26, 2022
    Date of Patent: May 23, 2023
    Assignee: LIQMEDS WORLDWIDE LIMITED
    Inventors: Sandip P. Mehta, Henil Alpeshbhai Patel, Jayanta Kumar Mandal
  • ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PROCESS OF PREPARATION THEREOF
    Publication number: 20230046943
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Application
    Filed: October 28, 2022
    Publication date: February 16, 2023
    Inventors: Swati NAGAR, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Sandeep PAL
  • LIQUID ORAL FORMULATIONS FOR SILDENAFIL
    Publication number: 20220409621
    Abstract: The present disclosure is directed to pharmaceutical compositions comprising sildenafil or a pharmaceutically acceptable salt thereof and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of sildenafil or a pharmaceutically acceptable salt thereof such as pulmonary arterial hypertension, erectile dysfunction, etc.
    Type: Application
    Filed: August 31, 2022
    Publication date: December 29, 2022
    Applicant: LIQMEDS WORLDWIDE LIMITED
    Inventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
  • Oral pharmaceutical composition comprising zonisamide and process of preparation thereof
    Patent number: 11529333
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: December 20, 2022
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Swati Nagar, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Sandeep Pal
  • Oral pharmaceutical composition comprising Zonisamide and process of preparation thereof
    Patent number: 11478456
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Grant
    Filed: March 15, 2022
    Date of Patent: October 25, 2022
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Swati Nagar, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Sandeep Pal
  • Liquid oral formulations for sildenafil
    Patent number: 11464778
    Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
    Type: Grant
    Filed: December 24, 2018
    Date of Patent: October 11, 2022
    Assignee: LIQMEDS WORLDWIDE LIMITED
    Inventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
  • LIQUID ORAL FORMULATIONS FOR TADALAFIL
    Publication number: 20220296602
    Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
    Type: Application
    Filed: June 6, 2022
    Publication date: September 22, 2022
    Inventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
  • AQUEOUS SUSPENSION SUITABLE FOR ORAL ADMINISTRATION
    Publication number: 20220280421
    Abstract: The present invention provides liquid oral dosage form of lipid lowering agent suitable for oral administration to human or animals.
    Type: Application
    Filed: May 26, 2022
    Publication date: September 8, 2022
    Applicant: LIQMEDS WORLDWIDE LIMITED
    Inventors: Sandip P. MEHTA, Henil Alpeshbhai PATEL, Jayanta Kumar MANDAL
  • Liquid oral formulations for tadalafil
    Patent number: 11382917
    Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
    Type: Grant
    Filed: August 16, 2021
    Date of Patent: July 12, 2022
    Assignee: LIQMEDS WORLDWIDE LIMITED
    Inventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
  • ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PROCESS OF PREPARATION THEREOF
    Publication number: 20220202782
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Application
    Filed: March 15, 2022
    Publication date: June 30, 2022
    Inventors: Swati Nagar, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Sandeep Pal
  • Aqueous suspension suitable for oral administration
    Patent number: 11369567
    Abstract: The present invention provides liquid oral dosage form of lipid lowering agent suitable for oral administration to human or animals.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: June 28, 2022
    Assignee: LIQMEDS WORLDWIDE LIMITED
    Inventors: Sandip P. Mehta, Henil Alpeshbhai Patel, Jayanta Kumar Mandal